NCT04767802Phase 2Completed
PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Study sponsor: Protagonist Therapeutics, Inc. · PTGX
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2023-03-15Actual
Enrollment · participants20Actual
Source updated2024-03-18Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.